Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04221984 · ClinicalTrials.gov registry record
Wingspan One Year Vascular Imaging Events and Neurologic Outcomes
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 129
- Enrollment target
NCT04221984: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT04221984 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04221984 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the one-year post stenting outcomes in patients who were treated with the Wingspan stent on-label in the WEAVE trial. This includes both the assessment of any stroke, hemorrhage, or death, as well as assessment of delayed imaging results to determine the re-stenosis rate of the stents in these patients.
Primary Outcome
1-year stroke rate following placement of Wingspan stent in this patient cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2020-05-19 |
What the finished NCT04221984 record still lists
NCT04221984 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04221984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04221984 about?
NCT04221984 is a clinical study titled "Wingspan One Year Vascular Imaging Events and Neurologic Outcomes". The purpose of the study is to determine the one-year post stenting outcomes in patients who were treated with the Wingspan stent on-label in the WEAVE trial. This includes both the assessment of any stroke, hemorrhage, or death, as well as assessment of delayed imaging results to determine the re-s...
What is the current status of trial NCT04221984?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2019-11-12. Estimated completion is 2020-05-19.
Who is sponsoring clinical trial NCT04221984?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI